Literature DB >> 17459875

Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794.

Alexandros Tzatsos1, Philip N Tsichlis.   

Abstract

Energy depletion activates AMP-activated protein kinase (AMPK) and inhibits cell growth via TSC2-dependent suppression of mTORC1 signaling. Long term energy depletion also induces apoptosis by mechanisms that are not well understood to date. Here we show that AMPK, activated by energy depletion, inhibited cell survival by binding to and phosphorylating IRS-1 at Ser-794. Phosphorylation of IRS-1 at this site inhibited phosphatidylinositol 3-kinase/Akt signaling, suppressed the mitochondrial membrane potential, and promoted apoptosis. Of the treatments promoting energy depletion, glucose deprivation, hypoxia, and inhibition of ATP synthesis in the mitochondria stimulated phosphorylation of IRS-1 at Ser-794 via an LKB1/AMPK-dependent manner, whereas oxidative stress and 2-deoxyglucose stimulated phosphorylation at this site via a Ca2+/calmodulin-dependent protein kinase kinase beta/AMPK axis. These data define a novel pathway that cooperates with other adaptive mechanisms to formulate the cellular response to energy depletion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459875     DOI: 10.1074/jbc.M610101200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Mitochondrial membrane potential in axons increases with local nerve growth factor or semaphorin signaling.

Authors:  Jessica Verburg; Peter J Hollenbeck
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

Review 2.  AMPK: An emerging target for modification of injury-induced pain plasticity.

Authors:  Theodore J Price; Gregory Dussor
Journal:  Neurosci Lett       Date:  2013-07-03       Impact factor: 3.046

3.  Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR.

Authors:  Alexandros Tzatsos
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

4.  Hypoxia leads to Na,K-ATPase downregulation via Ca(2+) release-activated Ca(2+) channels and AMPK activation.

Authors:  Galina A Gusarova; Humberto E Trejo; Laura A Dada; Arturo Briva; Lynn C Welch; Robert B Hamanaka; Gökhan M Mutlu; Navdeep S Chandel; Murali Prakriya; Jacob I Sznajder
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

5.  Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells.

Authors:  Junyu Ning; Gang Xi; David R Clemmons
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

Review 6.  Effects of AMP-activated protein kinase in cerebral ischemia.

Authors:  Jun Li; Louise D McCullough
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

7.  Effects of contraction and insulin on protein synthesis, AMP-activated protein kinase and phosphorylation state of translation factors in rat skeletal muscle.

Authors:  Lisa Miranda; Sandrine Horman; Isabelle De Potter; Louis Hue; Jørgen Jensen; Mark H Rider
Journal:  Pflugers Arch       Date:  2007-10-24       Impact factor: 3.657

8.  AMPK exerts dual regulatory effects on the PI3K pathway.

Authors:  Rong Tao; Jun Gong; Xixi Luo; Mengwei Zang; Wen Guo; Rong Wen; Zhijun Luo
Journal:  J Mol Signal       Date:  2010-02-18

9.  AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia.

Authors:  Gilles M Leclerc; Guy J Leclerc; Guilian Fu; Julio C Barredo
Journal:  J Mol Signal       Date:  2010-09-23

10.  Alpha1-AMP-activated protein kinase regulates hypoxia-induced Na,K-ATPase endocytosis via direct phosphorylation of protein kinase C zeta.

Authors:  Galina A Gusarova; Laura A Dada; Aileen M Kelly; Chaya Brodie; Lee A Witters; Navdeep S Chandel; Jacob I Sznajder
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.